Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 0 | 251 | 0 |
| Gross Profit | N/A | N/A | N/A | 251 | N/A |
| Operating Expenses | 18,265 | 18,335 | 16,190 | 14,743 | 0 |
| Operating Income | -18,265 | -18,335 | -16,190 | -14,492 | N/A |
| Other Income | 2,170 | 863 | -1,653 | 529 | 0 |
| Pre-tax Income | -16,095 | -17,472 | -17,843 | -13,963 | 0 |
| Net Income Continuous | -16,095 | -17,472 | -17,843 | -13,963 | N/A |
| Net Income | $-16,095 | $-17,472 | $-17,843 | $-13,963 | $N/A |
| EPS Basic Total Ops | 34.35 | -0.92 | -22.00 | -17.24 | N/A |
| EPS Basic Continuous Ops | 34.36 | -0.92 | -22.00 | -17.24 | N/A |
| EPS Diluted Total Ops | 34.35 | -0.92 | -22.00 | -17.24 | N/A |
| EPS Diluted Continuous Ops | 34.36 | -0.92 | -22.00 | -17.24 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -0.92 | -19.10 | N/A | N/A |
| EBITDA(a) | $-17,651 | $-17,708 | $-15,587 | $-13,905 | $N/A |